Idi na sadržaj

Alternative transfuziji krvi i financijska isplativost

Onkologija

Should intravenous iron be the standard of care in oncology? (otvara se novi prozor)

Auerbach M.

Izvor‎: J Clin Oncol 2008;26(10):1579-81.

Indeks‎: PubMed 18375888

DOI‎: 10.1200/JCO.2007.15.4609

https://www.ncbi.nlm.nih.gov/pubmed/18375888 (otvara se novi prozor)

Cost of outpatient blood transfusion in cancer patients. (otvara se novi prozor)

Crémieux PY, Barrett B, Anderson K, Slavin MB.

Izvor‎: J Clin Oncol 2000;18(14):2755-61.

Indeks‎: PubMed 10894876

DOI‎: 10.1200/JCO.2000.18.14.2755

https://www.ncbi.nlm.nih.gov/pubmed/10894876 (otvara se novi prozor)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (otvara se novi prozor)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Izvor‎: Transfusion 2015;55(12):2807-15.

Indeks‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (otvara se novi prozor)